Phages for methicillin-resistant Staphylococcus aureus: an international trial

J F Richardson1, V T Rosdahl, W J van Leeuwen

  • 1Campylobacter Reference Unit, Central Public Health Laboratory, London, UK.

Insights

New experimental phages significantly improve Staphylococcus aureus typing. These phages enhance the ability to identify methicillin-resistant Staphylococcus aureus (MRSA) strains, increasing typability and distinct lytic patterns for better global surveillance.

Area of Science:

  • Microbiology
  • Bacteriology
  • Epidemiology

Background:

  • The international phage set for Staphylococcus aureus typing shows reduced efficacy against methicillin-resistant strains (MRSA).
  • National typing centers utilize local experimental phages to overcome limitations with the international set.
  • There is a need to augment the international phage set for improved MRSA characterization.

Purpose of the Study:

  • To define a phage set that augments the international typing set for Staphylococcus aureus.
  • To evaluate the efficacy of locally isolated experimental phages in typing MRSA strains.
  • To establish a more comprehensive phage-based surveillance system for MRSA.

Main Methods:

  • Distribution of 42 experimental phages to 6 international centers.
  • Testing of phages against 744 clinical isolates of MRSA.
  • Selection and evaluation of a subset of 10 experimental phages.

Main Results:

  • The use of experimental phages increased MRSA typability from 75% to 93%.
  • The number of identifiable lytic patterns rose from 192 to 424 with the experimental set.
  • A subset of 10 phages achieved 91% typability and yielded 370 distinct patterns.

Conclusions:

  • Experimental phages significantly enhance the typing of MRSA strains.
  • A selected subset of 10 phages shows high efficacy and is suitable for international trial.
  • Augmenting the international phage set with these experimental phages improves global MRSA strain characterization and surveillance.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...